An isolated organ provides control over experimental conditions while removing much of the physiology that determines treatment performance in a living patient. Primary study
What was reported
Isolated rat hearts underwent global ischemia followed by reperfusion. MOTS-c was delivered through the perfusion system during early reperfusion. Selected exposures reduced injury measurements and improved mechanical recovery. The study also assessed oxidative and inflammatory markers and used computational docking to propose interactions with several signaling proteins. Primary report
Our appraisal: measured recovery and predicted binding are not equivalent evidence
Mechanical recovery is an observed result in the organ preparation. Docking is a computational prediction about a possible molecular interaction. Both can contribute to a research program, but they should not be presented as having the same evidentiary status.
A predicted interaction needs experimental confirmation, including whether binding occurs at relevant exposure and changes the proposed target's function. A favorable docking score alone does not prove pathway activation or identify the dominant mechanism.
The isolated-heart model also bypasses distribution and clearance. Delivering a substance in perfusion fluid does not establish what concentration would reach a human heart after systemic administration. It cannot define a clinical regimen.
Short-term recovery is another boundary. An early reduction in injury or improvement in pressure does not establish long-term survival, remodeling, or functional benefit after a human heart attack. Those are different endpoints requiring different designs.
This study is appropriately interpreted as proof-of-concept organ-level research with supporting mechanistic hypotheses. Its strongest claims concern the measured preparation, not validated molecular targets, human efficacy, or clinical dosing.
Frequently asked questions
Was this a patient trial?
No.
Were the hearts studied outside the body?
Yes.
Was mechanical recovery measured?
Yes.
Does docking prove binding in living tissue?
No.
Does perfusion exposure define a human regimen?
No.
Was long-term patient survival established?
No.
What is the appropriate evidence category?
Preclinical proof-of-concept research.